Literature DB >> 30974951

New insights on critical reagent optimization for antidrug antibody assays.

Agostinho G Rocha1, Katelyn Krynski1, Anthony Mancino1, Matthew Sciscione1, Christopher John Beaver1.   

Abstract

Aim: Conjugated critical reagents are a pillar of ligand binding analysis. Although good practices for characterization have already been discussed, little is known about how assays are affected by specific conjugation parameters.
Results: Here we developed, characterized and screened a toolset of bioconjugates that provided new insights about the optimization of conjugated critical reagent attributes. Biotinylated and sulfo-tagged trastuzumab were utilized as capture and detection antibodies, respectively, in an antidrug antibody (ADA) assay. The optimal conjugation window was identified by functional assessment. Excess of unlabeled biotin, but not sulfo-tag, affected the assay performance. An increase in the assay baseline was observed when sulfo-tagged trastuzumab underwent increasing freeze-thaw cycles.
Conclusion: Upfront systematic screening and characterization of conjugated critical reagent attributes benefit assay robustness.

Entities:  

Keywords:  ADA assay; ECL; biotin; critical reagents; sulfo-tag; trastuzumab

Mesh:

Substances:

Year:  2019        PMID: 30974951     DOI: 10.4155/bio-2019-0040

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

1.  A Tiered Approach for Characterization to Ensure Quality, Reproducibility, and Long-Term Stability of Critical Reagents in Regulated Bioanalysis to Support PK/ADA/NAb Assays for Biologics and Vaccines Programs.

Authors:  Kun Yang; Ying Zhang; Robert Chou; Lai Yeung; Simon Letarte; Rong-Sheng Yang; Xuanwen Li; Maribel Beaumont; Rico Gunawan; Douglas Richardson; Shara Dellatore; Eric Woolf; Yang Xu
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-28

Review 2.  Current Analytical Strategies for Antibody-Drug Conjugates in Biomatrices.

Authors:  Qiuping Qin; Likun Gong
Journal:  Molecules       Date:  2022-09-24       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.